Viral latency in blood and saliva of simian foamy virus-infected humans

PLoS One. 2013 Oct 8;8(10):e77072. doi: 10.1371/journal.pone.0077072. eCollection 2013.

Abstract

Simian foamy viruses (SFV) are widespread retroviruses among non-human primates (NHP). SFV actively replicate in the oral cavity and can be transmitted to humans through NHP bites, giving rise to a persistent infection. We aimed at studying the natural history of SFV infection in human. We have analyzed viral load and gene expression in 14 hunters from Cameroon previously shown to be infected with a gorilla SFV strain. Viral DNA could be detected by quantitative polymerase chain reaction (q-PCR) targeting the pol-in region, in most samples of peripheral blood mononuclear cells (PBMCs) (7.1 ± 6.0 SFV DNA copies/105 PBMCs) and saliva (2.4 ± 4.3 SFV DNA copies/105 cells) derived from the hunters. However, quantitative real-time reverse-transcription polymerase chain reaction (RT)-qPCR revealed the absence of SFV viral gene expression in both PBMCs and saliva, suggesting that SFV was latent in the human samples. Our study demonstrates that a latent infection can occur in humans and persist for years, both in PBMCs and saliva. Such a scenario may contribute to the putative lack of secondary human-to-human transmissions of SFV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • Blood / virology
  • DNA, Viral / isolation & purification
  • Humans
  • Leukocytes, Mononuclear / virology
  • Middle Aged
  • Retroviridae Infections / blood*
  • Retroviridae Infections / diagnosis
  • Retroviridae Infections / virology*
  • Saliva / virology*
  • Simian foamy virus / isolation & purification
  • Simian foamy virus / physiology*
  • Virus Latency*
  • Young Adult

Substances

  • DNA, Viral

Grants and funding

R. Rua was personally supported by the “Bourse de l’Ecole Normale Supérieure, Faculté Paris Diderot ”. E. Betsem was supported by the “Association Virus Cancer Prevention” and the Institut National pour le Cancer. Financial support was also provided by the Institut Pasteur in Paris. This study has received funding from the French Government’s Investissement d’Avenir program, Laboratoire d’Excellence « Integrative Biology of Emerging Infectious Diseases » (grant n°ANR-10-LABX-62-IBEID ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.